Proteomics International Laboratories Site Visit

A group from Euroz Hartleys were pleased to have the opportunity to visit Proteomics International Laboratories Ltd’s (ASX: PIQ) state-of-the art facilities at the Harry Perkins Institute of Medical Research earlier this week. Advisers were provided with a close up look of the Company’s highly specialised labs and equipment. We look forward to an exciting 2021 year for Proteomics as it continues to commercialise its novel predictive diabetic kidney disease test “PromarkerD”